Home Cell Cycle CDK inhibitor K03861 (AUZ454) For research use only.

K03861 (AUZ454)

K03861 (AUZ454) is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for CDK2(WT), CDK2(C118L), CDK2(A144C), and CDK2(C118L/A144C), respectlvely.

K03861 (AUZ454) Chemical Structure

K03861 (AUZ454) Chemical Structure

CAS: 853299-07-7

Selleck's K03861 (AUZ454) has been cited by 13 publications

Purity & Quality Control

Batch: Purity: 99.05%
99.05

K03861 (AUZ454) Related Products

Signaling Pathway

CDK Signaling Pathways

CDK Signaling Pathway

Choose Selective CDK Inhibitors

Biological Activity

Description K03861 (AUZ454) is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for CDK2(WT), CDK2(C118L), CDK2(A144C), and CDK2(C118L/A144C), respectlvely.
Targets
CDK2(C118L/A144C) [1]
(Cell-free assay)		 CDK2(A144C) [1]
(Cell-free assay)		 CDK2(C118L) [1]
(Cell-free assay)		 CDK2(WT) [1]
(Cell-free assay)
9.7 nM(Kd) 15.4 nM(Kd) 18.6 nM(Kd) 50 nM(Kd)
In vitro
In vitro K03861 inhibits CDK2 activity by competing with binding of activating cyclins. [1]

Chemical Information & Solubility

Molecular Weight 501.50 Formula

C24H26F3N7O2
CAS No. 853299-07-7 SDF Download K03861 (AUZ454) SDF
Smiles CN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC(=NC=C4)N)C(F)(F)F
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 100 mg/mL ( (199.4 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 15 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy K03861 (AUZ454) | K03861 (AUZ454) supplier | purchase K03861 (AUZ454) | K03861 (AUZ454) cost | K03861 (AUZ454) manufacturer | order K03861 (AUZ454) | K03861 (AUZ454) distributor